STOCKHOLM, May 15th, 2019. Moberg Pharma AB’s (“Company”) Annual General Meeting took place on Wednesday, May 15th, 2019 in the Company´s premises in Bromma, Sweden.
Adoption of the income statements and the balance sheets
The Annual General Meeting (the “Meeting”) approved the income statements and the balance sheets for the fiscal year 2018.
The Meeting resolved, in accordance with the proposal of the Board of Directors, that no dividend should be paid for the fiscal year 2018.
The Meeting discharged the Board members and the Chief Executive Officer from liability for the fiscal